Status:
COMPLETED
Assessment of Blood Glucose Monitoring Systems - Evaluation of Oxygen Dependency
Lead Sponsor:
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Collaborating Sponsors:
Roche Diagnostics GmbH
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Systems for blood glucose monitoring with glucose oxidase enzyme reaction on test strips can be affected by the partial pressure of oxygen of the blood sample. In this study, we investigate the influe...
Eligibility Criteria
Inclusion
- 18 years of age or older
- male or female subjects with type 1 or type 2 diabetes or healthy subjects
- signed informed consent form
Exclusion
- pregnancy or lactation period
- severe acute illness that, in the opinion of the investigator, might pose additional risk to the subject
- severe chronic illness that, in the opinion of the investigator, might pose additional risk to the subject
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01871831
Start Date
June 1 2013
End Date
October 1 2013
Last Update
January 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft an der Universität Ulm
Ulm, Germany, 89081